Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms - PubMed (original) (raw)
Review
. 1995 Apr;61(4 Suppl):980S-986S.
doi: 10.1093/ajcn/61.4.980S.
Affiliations
- PMID: 7900697
- DOI: 10.1093/ajcn/61.4.980S
Review
Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms
J M Olefsky et al. Am J Clin Nutr. 1995 Apr.
Abstract
Non-insulin-dependent diabetes mellitus is a complex metabolic disorder that involves numerous biochemical abnormalities, a heterogenous clinical picture, and a polygenic hereditary component. The pathophysiologic state involves increased basal hepatic glucose production, decreased insulin-mediated glucose utilization in target tissues, and altered pancreatic function with decreased beta cell function and enhanced glucagon secretion. Prospective studies indicate that insulin resistance and hyperinsulinemia exist in the prediabetic state at a time when glucose tolerance is normal. When hyperglycemia supervenes, both insulin secretion and insulin-mediated glucose utilization are further compromised, mediated in part by sustained hyperglycemia itself. Insulin resistance may occur at any level in the biologic action of insulin, from initial binding to cell surface receptors to the phosphorylation cascade that is initiated by autophosphorylation of the insulin receptor. Receptors isolated from patients with non-insulin-dependent diabetes mellitus have compromised autophosphorylation-kinase activity when isolated from adipocytes, liver, erythrocytes, and skeletal muscle. The magnitude of the decrease in insulin receptor kinase activity is correlated with the degree of fasting hyperglycemia. However, the defect in insulin receptor kinase activity is normalized after weight reduction or other measures that reduce hyperglycemia, indicating the secondary nature of the defect. Clarification of the mechanisms underlying insulin resistance in non-insulin-dependent diabetes mellitus will lead to new treatment modalities for this disease.
Similar articles
- Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
Olefsky JM, Revers RR, Prince M, Henry RR, Garvey WT, Scarlett JA, Kolterman OG. Olefsky JM, et al. Adv Exp Med Biol. 1985;189:176-205. Adv Exp Med Biol. 1985. PMID: 3898763 - Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
Halter JB, Ward WK, Porte D Jr, Best JD, Pfeifer MA. Halter JB, et al. Am J Med. 1985 Aug 23;79(2B):6-12. doi: 10.1016/0002-9343(85)90579-0. Am J Med. 1985. PMID: 2863979 Review. - Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
Porte D Jr, Kahn SE. Porte D Jr, et al. Am J Med. 1991 Jun 24;90(6A):8S-14S. doi: 10.1016/0002-9343(91)90412-q. Am J Med. 1991. PMID: 1872310 Review. - Islet dysfunction in non-insulin-dependent diabetes mellitus.
Kahn SE, Porte D Jr. Kahn SE, et al. Am J Med. 1988 Nov 28;85(5A):4-8. doi: 10.1016/0002-9343(88)90392-0. Am J Med. 1988. PMID: 3057894 Review. - Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
Reaven GM. Reaven GM. Diabetes Care. 1984 May-Jun;7 Suppl 1:17-24. Diabetes Care. 1984. PMID: 6376025 Review.
Cited by
- Insulin resistance in non-insulin-dependent diabetes mellitus. A review.
Alzaid AA. Alzaid AA. Acta Diabetol. 1996 Jul;33(2):87-99. doi: 10.1007/BF00569416. Acta Diabetol. 1996. PMID: 8870808 Review. No abstract available. - Population Attributable Fraction for Cardiovascular Diseases Risk Factors in Selected Countries: A comparative study.
Pirani N, Khiavi FF. Pirani N, et al. Mater Sociomed. 2017 Mar;29(1):35-39. doi: 10.5455/msm.2017.29.35-39. Mater Sociomed. 2017. PMID: 28484352 Free PMC article. - Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines.
Kulkarni RN, Winnay JN, Daniels M, Brüning JC, Flier SN, Hanahan D, Kahn CR. Kulkarni RN, et al. J Clin Invest. 1999 Dec;104(12):R69-75. doi: 10.1172/JCI8339. J Clin Invest. 1999. PMID: 10606633 Free PMC article. - Oral bioavailability and pharmacokinetics of PAT-5A, a new insulin sensitizer in rats.
Mamidi RN, Katneni K, Mullangi R, Ramanujam R. Mamidi RN, et al. Eur J Drug Metab Pharmacokinet. 2002 Jul-Sep;27(3):175-8. doi: 10.1007/BF03190454. Eur J Drug Metab Pharmacokinet. 2002. PMID: 12365198 - Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort.
Rumawas ME, Meigs JB, Dwyer JT, McKeown NM, Jacques PF. Rumawas ME, et al. Am J Clin Nutr. 2009 Dec;90(6):1608-14. doi: 10.3945/ajcn.2009.27908. Epub 2009 Oct 14. Am J Clin Nutr. 2009. PMID: 19828705 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical